A study measuring Engagement with an ad and landing page designed for Suicide prevention using Google Adwords for participants in Australia and Indonesia, targetting Individuals who have not sought Help
This study is not yet recruiting in Australia and in Indonesia. It focuses on Suicide.
SuicidalityOtherFrom 13 Years to No limit
The public registry lists this study as not yet recruiting. Check the official record and ask the research team when recruitment may open.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What the source says
The registry describes this research topic: “Identifying and Reaching Individuals who have not sought Help for Suicide using Google Ads”. This is an interventional study. The registry lists a target sample size of 800. Recruitment status at the registry update of 2023-11-17: not yet recruiting. Read the original description and eligibility criteria, and confirm the practical details with the study team.
What should you check before joining?
Check the full criteria in the official source. Ask the team to confirm recruitment, locations, visits, risks and participation requirements.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateNovember 30, 2023
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
800
Sponsor
UNSW Sydney
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
Prevention
Study phase
Not ApplicableFormal phases are mostly used for medication studies and some device studies. Some studies do not use a phase.
Locations
Australia, Indonesia
Age range
From 13 Years to No limit
Official registry ID
ACTRN12623001188628
Official title
A Trial measuring Engagement with an ad and landing page designed for suicide prevention using Google Adwords for participants in Australia and Indonesia, targetting Individuals who have not sought Help
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: ACTRN12623001188628. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
No specific site is confirmed in the available information. Check the official source for locations and remote participation.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Confirm the location and whether remote participation is possible with the research team.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring observational follow-up for people with suicide prevention. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Why is the study type not clearly categorized?
The study type is not clearly categorized in the public registry. Focus on the objective, required tasks, visits, any intervention, and eligibility criteria, then ask the study team to confirm.
Who might this study be for?
This study may concern people with suicide prevention; age range: From 13 Years to No limit. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
The public registry does not clearly describe all participation steps. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What risks or points should I check?
The public registry does not make the main risk category clear. Ask the study team what activities are required, what could feel uncomfortable, how safety is monitored, and what happens if you want to stop. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by UNSW Sydney, which appears to be unknown or unclear. The listed contact or investigator is Sandersan Onie. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not yet recruiting. Check the official record and ask the research team when recruitment may open.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
